Prophylactic indomethacin for preterm infants: a systematic review and meta-analysis

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Archives of Disease in Childhood: Fetal and Neonatal Edition

• Publication date

  2003-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/fn.88.6.F464PMID 14602691PMCID PMC1763231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Patent ductus arteriosus in preterm neonates

  2001cited by this paper
• Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants.

  2001cited by this paper
• Intravenous indomethacin for preventing mortality and morbidity in very low birth weight infants.

  2000cited by this paper
• Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.

  1999cited by this paper
• Effects of early indomethacin administration on oxygenation and surfactant requirement in low birth weight infants.

  1997cited by this paper
• Prophylactic indomethacin: systematic review and meta-analysis.

  1996cited by this paper
• Nutritional management of cystic fibrosis.

  1996cited by this paper
• Prophylactic indomethacin therapy in the first twenty-four hours of life for the prevention of patent ductus arteriosus in preterm infants treated prophylactically with surfactant in the delivery room.

  1996cited by this paper
• Low-dose indomethacin therapy and extension of intraventricular hemorrhage: a multicenter randomized trial.

  1994cited by this paper
• Low-dose indomethacin and prevention of intraventricular hemorrhage: a multicenter randomized trial.

  1994cited by this paper
• Indomethacin reduces the risks of severe intraventricular hemorrhage.

  1989cited by this paper
• Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants.

  1988cited by this paper
• Administration of indomethacin for the prevention of periventricular-intraventricular hemorrhage in high-risk neonates.

  1988cited by this paper
• Randomized low-dose indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight neonates.

  1988cited by this paper
• Prevention of symptomatic patent ductus arteriosus with a single dose of indomethacin.

  1987cited by this paper
• Early Intravenous Indomethacin Prolongs Respiratory Support in Very Low Birth Weight Infants

  1987cited by this paper
• Early administration of indomethacin to preterm infants.

  1986cited by this paper
• Randomized indomethacin trial for prevention of intraventricular hemorrhage in very low birth weight infants.

  1985cited by this paper
• Indomethacin therapy on the first day of life in infants with very low birth weight.

  1985cited by this paper
• 1488 PROPHYLACTIC INDOMETHACIN (I) FOR THE PREVENTION OF PATENT DUCTUS ARTERIOSUS (PDA)

  1985cited by this paper
• Characterization of HCO3-/CO2 pool sizes and kinetics in infants.

  1985cited by this paper

• Blood flow assessment in echocardiography of hemodynamically significant patent ductus arteriosus in preterm infants.

  2025cites this paper
• Recommitting to Rules of Evidence and Laws of Inference.

  2024cites this paper
• Proactive Diagnosis and Tailor-Made Treatment of Patent Ductus Arteriosus in Very Preterm Infants with Routine Echocardiography in Japan: A post hoc Analysis of the PLASE Study

  2024cites this paper
• Modern possibilities and prospects of tocolytic therapy

  2024cites this paper
• Patent Ductus Arteriosus (PDA): Recent Recommendations for to Close or Not to Close

  2023cites this paper
• Surgical ligation, not transcatheter closure, associated with a higher severity of bronchopulmonary dysplasia in extremely preterm infant intervened for patent ductus arteriosus

  2023cites this paper
• An Update on Patent Ductus Arteriosus and What is Coming Next

  2022cites this paper
• The Association of Patent Ductus Arteriosus with Inflammation: A Narrative Review of the Role of Inflammatory Biomarkers and Treatment Strategy in Premature Infants

  2022cites this paper
• Effects of prophylactic indomethacin on intraventricular hemorrhage and adverse outcomes in neonatal intensive care unit

  2022cites this paper
• Use of Prophylactic Indomethacin in Preterm Infants: A Systematic Review and Meta-Analysis

  2022cites this paper
• Secukinumab attenuates neuroinflammation and neurobehavior defect via PKCβ/ERK/NF-κB pathway in a rat model of GMH.

  2021cites this paper
• Germinal Matrix -Intraventricular Hemorrhage: Current Concepts and Future Direction

  2021cites this paper
• MANAGEMENT STRATEGIES OF PATENT DUCTUS ARTERIOSUS IN PRETERM INFANTSREVIEW ARTICLE

  2021cites this paper
• Massive Gastric Hemorrhage after Indomethacin Therapy: A Rare Presentation and Critical Management in an Extremely Preterm Infant

  2021cites this paper
• Respiratory Trajectory after Invasive Interventions for Patent Ductus Arteriosus of Preterm Infants

  2021cites this paper
• Use of Prophylactic Indomethacin in Preterm Infants: A Systematic Review and Meta-analysis

  2020influential citation
• Patent Ductus Arteriosus

  2020cites this paper
• A Model of Germinal Matrix Hemorrhage in Preterm Rat Pups

  2020cites this paper
• Neuroprotective effect of indomethacin in normal perfusion pressure breakthrough phenomenon

  2020cites this paper
• Decision aids available for parents making end‐of‐life or palliative care decisions for children: A scoping review

  2020cites this paper
• Erythropoietin Improves Atrophy, Bleeding and Cognition in the Newborn Intraventricular Hemorrhage

  2020cites this paper
• The optimal choices of animal models of white matter injury

  2019cites this paper
• A single-dose indomethacin prophylaxis for reducing perinatal brain injury in extremely low birth weight infants: a non-inferiority analysis

  2019cites this paper
• Intraperitoneal cannabidiol attenuates neonatal germinal matrix hemorrhage-induced neuroinflamation and perilesional apoptosis

  2019cites this paper
• What echocardiographic indices are predictive of patent ductus arteriosus surgical closure in early preterm infants? A prospective multicenter cohort study.

  2019cites this paper
• Recent advances in perinatal neuroprotection

  2019cites this paper
• Enhancing Oligodendrocyte Myelination Rescues Synaptic Loss and Improves Functional Recovery after Chronic Hypoxia.

  2018cites this paper
• Lack of relationship between cord blood erythropoietin and intraventricular hemorrhage in premature neonates: a controversial result

  2018cites this paper
• Preterm Intraventricular Hemorrhage/Posthemorrhagic Hydrocephalus

  2018cites this paper
• 22 – Injury to the Developing Preterm Brain: Intraventricular Hemorrhage and White Matter Injury

  2017cites this paper
• Outcomes following indomethacin prophylaxis in extremely preterm infants in an all-referral NICU

  2017cites this paper
• Pharmacological Closure of Patent Ductus Arteriosus: Selecting the Agent and Route of Administration

  2016cites this paper
• Persistência do canal arterial

  2015cites this paper
• Antenatal exposure to indomethacin increases the risk of severe intraventricular hemorrhage, necrotizing enterocolitis, and periventricular leukomalacia: a systematic review with metaanalysis.

  2015cites this paper
• Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants (EpoRepair)

  2015cites this paper
• Pharmacological Preventions of Brain Injury Following Experimental Germinal Matrix Hemorrhage: an Up-to-Date Review

  2015cites this paper
• Safety of therapeutics used in management of patent ductus arteriosus in preterm infants.

  2015cites this paper
• Acute Respiratory Care of the Neonate 10 Complications of Positive Pressure Ventilation

  2015cites this paper
• A prospective study of maternal preference for indomethacin prophylaxis versus symptomatic treatment of a patent ductus arteriosus in preterm infants

  2015cites this paper
• Pathogenesis and prevention of intraventricular hemorrhage.

  2014cites this paper
• Current controversies in the management of patent ductus arteriosus in preterm infants

  2014cites this paper
• A risk prediction model for severe intraventricular hemorrhage in very low birth weight infants and the effect of prophylactic indomethacin

  2014cites this paper
• Impact of Perinatal White Matter Injury on Preterm Survivors

  2014cites this paper
• Pathophysiology of glia in perinatal white matter injury

  2014cites this paper
• Effects of Intravenous Indomethacin on Reduction of Symptomatic Patent Ductus Arteriosus Cases and Decreasing the Need for Prolonged Mechanical Ventilation

  2014cites this paper
• Patent Ductus Arteriosus in Preterm Infants Utility of Rapid B-Type Natriuretic Peptide Assay for Diagnosis of Symptomatic

  2013cites this paper
• Treatment of Intraventricular Hemorrhages in Premature Infants: Where Is the Evidence?

  2013cites this paper
• Clinical Pharmacology of Indomethacin in Preterm Infants: Implications in Patent Ductus Arteriosus Closure

  2013cites this paper
• Early echocardiographic prediction of ductal closure in neonates ⩽30 weeks gestation

  2013cites this paper
• Indomethacin prophylaxis to prevent intraventricular hemorrhage: association between incidence and timing of drug administration.

  2013cites this paper
• Serial echocardiography in very preterm infants: a pilot randomized trial

  2013cites this paper
• Prophylactic Indomethacin Worsens Short-Term Respiratory Outcomes in Extremely Low-Birth-Weight Infants

  2013cites this paper
• The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia.

  2013cites this paper
• Acute Neonatal Respiratory Failure

  2013cites this paper
• IMMUNMODULATORISCHER EFFEKT VON BETAMETHASON UND INDOMETACIN AUF DIE ZYTOKINPRODUKTION FETALER MONONUKLEÄRER ZELLEN NACH STIMULATION MIT LPS

  2013cites this paper
• Patent Ductus Arteriosus

  2013influential citation
• Role of Ion Channels in Ductus Arteriosus Closure

  2013cites this paper
• High‐dose calcium reduces early‐onset hyperkalemia in extremely preterm neonates

  2012cites this paper
• Early versus Conventional Treatment for Patent Ductus Arteriosus in Preterm Infants

  2012cites this paper
• Patent Ductus Arteriosus in Premature Neonates

  2012cites this paper
• Neurodevelopmental Outcomes Following Two Different Treatment Approaches (Early Ligation versus Selective Ligation) for Patent Ductus Arteriosus

  2012cites this paper
• Mechanisms of Hydrocephalus After Neonatal and Adult Intraventricular Hemorrhage

  2012cites this paper
• Neonatal Intracerebral Hemorrhage: Mechanisms, Managements, and the Outcomes

  2012cites this paper
• Pharmacological Management of PDA: oral versus intravenous medications.

  2012cites this paper
• Neurodevelopmental outcomes following two different treatment approaches (early ligation and selective ligation) for patent ductus arteriosus.

  2012cites this paper
• Usefulness of Serum Brain Natriuretic Peptide Level for Screening Hemodynamically Significant Patent Ductus Arteriosus in Preterm Neonates

  2012cites this paper
• NT-proBNP Levels Improve the Ability of Predicting a Hemodynamically Significant Patent Ductus Arteriosus in Very Low-Birth-Weight Infants

  2012influential citation
• A decision aid for considering indomethacin prophylaxis vs. symptomatic treatment of PDA for extreme low birth weight infants

  2011cites this paper
• Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus

  2011cites this paper
• Opposite effect of inflammation on subventricular zone versus hippocampal precursors in brain injury

  2011cites this paper
• Mechanisms Regulating Closure of the Ductus Arteriosus

  2011cites this paper
• Treatment Results After Ductal Closure in Extremely Low Gestational Age Infants

  2011cites this paper
• INVITED LECTURES

  2010cites this paper
• Ibuprofen Treatment for Closure of Patent Ductus Arteriosus Is Not Associated With Increased Risk of Neuropathology

  2010cites this paper
• Patent ductus arteriosus in premature infants: A never-closing act.

  2010cites this paper
• Patent Ductus Arteriosus of the Preterm Infant

  2010cites this paper
• Ecocardiografia doppler y doppler tisular en recien nacido pretérmino: influencia del ductus arterioso y foramen oval en el llenado ventricular izquierdo y su correlación con la evolución clínica

  2010cites this paper
• Niveaux de preuves versus pratiques cliniques : l’exemple de l’extrême prématurité

  2009cites this paper
• Intracranial hemorrhage in the preterm infant: understanding it, preventing it.

  2009cites this paper
• Patterns of Respiratory Disease During the First 2 Postnatal Weeks in Extremely Premature Infants

  2009cites this paper
• Patent Ductus Arteriosus Therapy: Impact on Neonatal and 18-Month Outcome

  2009cites this paper
• [Evidence versus experience in neonatal practice: the example of extremely premature infants].

  2009cites this paper
• Prophylactic indomethacin in extremely premature infants between 23 and 24 weeks gestation

  2009cites this paper
• The Impact of an Early Ibuprofen Treatment Protocol on the Incidence of Surgical Ligation of the Ductus Arteriosus

  2009cites this paper
• N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants

  2009cites this paper
• Patent Ductus Arteriosus

  2009cites this paper
• Delayed Neonatal Closure of the Ductus Arteriosus Following Early in utero Exposure to Indomethacin in the Rat

  2009cites this paper
• Does prophylactic treatment of patent ductus arteriosus affect utilization of hospital resources?

  2009cites this paper
• Social Competence at Age 4 Years, of Children Born Very Preterm

  2009cites this paper
• Genetic Contribution to Patent Ductus Arteriosus in the Premature Newborn

  2009cites this paper
• Ductus Arteriosus Treatment in the Premature Newborn : Clinical and Surgical Analysis

  2008cites this paper
• The pharmacological treatment of patent ductus arteriosus in premature infants with respiratory distress syndrome: oral ibuprofen vs. indomethacin

  2008cites this paper
• Chapter 5A – Intraventricular Hemorrhage and Posthemorrhagic Hydrocephalus

  2008cites this paper
• Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants

  2008cites this paper
• Respiratory Disorders of the Newborn

  2008cites this paper
• Role of echocardiography in management of PDA

  2008cites this paper
• Prophylaxis of symptomatic patent ductus arteriosus with oral ibuprofen in very low birth weight infants.

  2008influential citation
• N-TERMINAL PRO–BRAIN NATRIURETIC PEPTIDE AND PATENT DUCTUS ARTERIOSUS IN PRETERM INFANTS

  2008cites this paper
• The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate.

  2008cites this paper
• Patent ductus arteriosus treatment in the premature newborn: clinical and surgical analisys.

  2008cites this paper